𝔖 Bobbio Scriptorium
✦   LIBER   ✦

hMLH1promoter hypermethylation and MSI status in human endometrial carcinomas with and without metastases

✍ Scribed by J. Bischoff,A. Ignatov,A. Semczuk,C. Schwarzenau…

Book ID
126353951
Publisher
Springer
Year
2012
Tongue
English
Weight
488 KB
Volume
29
Category
Article
ISSN
0262-0898

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

RASSF1A hypermethylation and its inverse
RASSF1A hypermethylation and its inverse correlation with BRAF and/or KRAS mutations in MSI-associated endometrial carcinoma
✍ Sokbom Kang; Jae Myun Lee; Eun-Sook Jeon; Sun Lee; Hogeun Kim; Hy-Sook Kim; Sang 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 153 KB

## Abstract Both hypermethylation of the tumor suppressor gene __RASSF1A__ and activating mutations of the __KRAS__ and/or __BRAF__ gene have been reported in a variety of human cancers. To investigate these epigenetic and genetic alterations in endometrial carcinoma (EC), we examined their frequen

Expression of ps2 protein in endometrial
Expression of ps2 protein in endometrial carcinomas: Correlation with clinicopathologic features and sex steroid receptor status
✍ Masafumi Koshiyama; Masumi Yoshida; Mitsunaga Konishi; Maki Takemura; Yasuichiro 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 529 KB

Using immunohistochemistry, we examined pS2 expression in 64 samples of endometrial carcinoma, 11 samples of endometrial hyperplasia and 15 samples of normal endometrium, and compared them with clinicopathological data, estrogen receptor (ER) expression and progesterone receptor (PR) expression. Of